Estrogen receptor negative breast cancers express estrogen receptor mRNA

被引：0
作者：
Arnaout, A. [1 ]
McMahon, C. [1 ]
Seth, A. [1 ]
Slingerland, J. [2 ]
机构：
[1] Univ Toronto, Sunnybrook Hosp, Halifax, NS, Canada
[2] Univ Miami, Miami, FL 33152 USA
来源：
EJC SUPPLEMENTS | 2004年 / 2卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(04)91003-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
400
引用
收藏
页码：173 / 173
页数：1
相关论文
共 50 条
  • [1] Estrogen receptor negative breast cancers express estrogen receptor mRNA
    C. McMahon
    A. Alkarain
    A. Seth
    J. Slingerland
    Annals of Surgical Oncology, 2004, 11 : S50 - S50
  • [2] Estrogen receptor negative breast cancers express estrogen receptor mRNA
    McMahon, C
    Alkarain, A
    Seth, A
    Slingerland, J
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S50 - S50
  • [3] WHY ARE ESTROGEN-RECEPTOR-NEGATIVE BREAST CANCERS MORE AGGRESSIVE THAN THE ESTROGEN-RECEPTOR-POSITIVE BREAST CANCERS
    SHEIKH, MS
    GARCIA, M
    PUJOL, P
    FONTANA, JA
    ROCHEFORT, H
    INVASION & METASTASIS, 1994, 14 (1-6) : 329 - 336
  • [4] Sex Hormone Levels and Risks of Estrogen Receptor-Negative and Estrogen Receptor-Positive Breast Cancers
    Farhat, Ghada N.
    Cummings, Steven R.
    Chlebowski, Rowan T.
    Parimi, Neeta
    Cauley, Jane A.
    Rohan, Thomas E.
    Huang, Alison J.
    Vitolins, Mara
    Hubbell, F. Allan
    Manson, JoAnn E.
    Cochrane, Barbara B.
    Lane, Dorothy S.
    Lee, Jennifer S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (07): : 562 - 570
  • [5] GATA3 Is a Marker of Estrogen Receptor-Positive but Not Estrogen Receptor-Negative Breast Cancers
    Piscuoglio, S.
    Wen, Y. H.
    Martelotto, L. G.
    Rocco, E. Guerini
    Akram, M.
    Jungbluth, A. A.
    Brogi, E.
    Weigelt, B.
    Reis-Filho, J. S.
    MODERN PATHOLOGY, 2014, 27 : 76A - 76A
  • [6] GATA3 Is a Marker of Estrogen Receptor-Positive but Not Estrogen Receptor-Negative Breast Cancers
    Piscuoglio, S.
    Wen, Y. H.
    Martelotto, L. G.
    Rocco, E. Guerini
    Akram, M.
    Jungbluth, A. A.
    Brogi, E.
    Weigelt, B.
    Reis-Filho, J. S.
    LABORATORY INVESTIGATION, 2014, 94 : 76A - 76A
  • [7] Genes Dysregulated to Different Extent or Oppositely in Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancers
    Zhou, Xianxiao
    Shi, Tongwei
    Li, Bailiang
    Zhang, Yuannv
    Shen, Xiaopei
    Li, Hongdong
    Hong, Guini
    Liu, Chunyang
    Guo, Zheng
    PLOS ONE, 2013, 8 (07):
  • [8] Evaluation of prognostic markers in negative estrogen - progesterone receptor breast cancers
    Frangou-Plemenou, M.
    Kairi-Vassilatou, E.
    Karandrea, D.
    Apostolidi, M.
    Vouza, E.
    Tsantopoulos, M.
    Kondi-Pafiti, A.
    VIRCHOWS ARCHIV, 2009, 455 : 192 - 193
  • [9] NFIB is a potential target for estrogen receptor-negative breast cancers
    Moon, Hyeong-Gon
    Hwang, Ki-Tae
    Kim, Jeong-Ah
    Kim, Hee Sung
    Lee, Min-Joo
    Jung, Eun-Mi
    Ko, Eunyoung
    Han, Wonshik
    Noh, Dong-Young
    MOLECULAR ONCOLOGY, 2011, 5 (06) : 538 - 544
  • [10] Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers
    Archey, WB
    McEachern, KA
    Robson, M
    Offit, K
    Vaziri, SAJ
    Casey, G
    Borg, Å
    Arrick, BA
    ONCOGENE, 2002, 21 (46) : 7034 - 7041
12345